Fields »
ABOUT
HELP
BLOG

377 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
LAMA2Laminin, alpha 2
Urothelial cancer: 3.65e-5
Tissue enhancedplacenta:148.7
IMPDH1IMP (inosine 5'-monophosphate) dehydrogenase 1
Cytosol
Rods & Rings		Renal cancer: 1.78e-12
Liver cancer: 1.12e-7
Urothelial cancer: 3.72e-5
Glioma: 1.17e-4
Cervical cancer: 3.87e-4
Expressed in all
FLNCFilamin C, gamma
Plasma membrane
Cytosol		Lung cancer: 2.17e-5
Urothelial cancer: 3.73e-5
Glioma: 2.14e-4
Renal cancer: 5.69e-4
Tissue enhancedskeletal muscle:384.8
TPST1Tyrosylprotein sulfotransferase 1
CytosolRenal cancer: 8.16e-6
Urothelial cancer: 3.73e-5
Stomach cancer: 8.78e-4
Mixed
DIXDC1DIX domain containing 1
CytosolUrothelial cancer: 4.19e-5
Renal cancer: 6.89e-5
Mixed
ADAM17ADAM metallopeptidase domain 17
CytosolUrothelial cancer: 4.23e-5
Expressed in all
PROS1Protein S (alpha)
Urothelial cancer: 4.42e-5
Stomach cancer: 8.35e-4
Tissue enhancedliver:177.6
PNMA1Paraneoplastic Ma antigen 1
Focal adhesion sites
Cytosol		Liver cancer: 3.00e-5
Urothelial cancer: 4.51e-5
Head and neck cancer: 7.49e-5
Expressed in all
CALUCalumenin
Endoplasmic reticulumRenal cancer: 1.30e-11
Urothelial cancer: 4.60e-5
Liver cancer: 1.80e-4
Expressed in all
GPHNGephyrin
Cytoplasmic bodiesRenal cancer: 5.25e-12
Urothelial cancer: 4.61e-5
Expressed in all
CSPG4Chondroitin sulfate proteoglycan 4
Nucleus
Plasma membrane		Renal cancer: 7.60e-6
Urothelial cancer: 4.93e-5
Mixed
MYCV-myc avian myelocytomatosis viral oncogene homolog
NucleoplasmRenal cancer: 5.49e-8
Urothelial cancer: 4.96e-5
Ovarian cancer: 7.52e-4
Expressed in all
EIF3JEukaryotic translation initiation factor 3, subunit J
CytosolUrothelial cancer: 4.96e-5
Expressed in all
DYMDymeclin
Golgi apparatusRenal cancer: 2.76e-5
Urothelial cancer: 5.26e-5
Expressed in all
ATP8B2ATPase, aminophospholipid transporter, class I, type 8B, member 2
Golgi apparatus
Vesicles
Cytosol		Urothelial cancer: 5.29e-5
Pancreatic cancer: 1.60e-4
Mixed
MAP7D3MAP7 domain containing 3
CentrosomeUrothelial cancer: 5.38e-5
Endometrial cancer: 9.00e-5
Stomach cancer: 7.91e-4
Mixed
DPYSL2Dihydropyrimidinase-like 2
Plasma membrane
Cytosol		Urothelial cancer: 5.41e-5
Expressed in all
ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif, 15N/A
CytosolUrothelial cancer: 5.63e-5
Glioma: 9.00e-4
Lung cancer: 9.72e-4
Tissue enhancedadipose tissue:30.2
placenta:23.5
SVILSupervillin
Plasma membrane
Actin filaments
Cytosol		Urothelial cancer: 5.70e-5
Expressed in all
SSFA2Sperm specific antigen 2
Nucleus
Plasma membrane
Cytosol		Renal cancer: 2.91e-5
Urothelial cancer: 5.79e-5
Pancreatic cancer: 8.19e-4
Expressed in all
NBASNeuroblastoma amplified sequence
Nuclear membrane
Nucleoli
Golgi apparatus		Urothelial cancer: 5.84e-5
Liver cancer: 1.10e-4
Expressed in all
KDELC2KDEL (Lys-Asp-Glu-Leu) containing 2
Nucleoplasm
Vesicles		Urothelial cancer: 6.27e-5
Liver cancer: 1.45e-4
Expressed in all
SERPINE2Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
Urothelial cancer: 6.48e-5
Tissue enriched7placenta:1612.5
ANXA2Annexin A2
Renal cancer: 2.11e-6
Pancreatic cancer: 8.47e-6
Liver cancer: 2.54e-5
Urothelial cancer: 6.59e-5
Endometrial cancer: 6.88e-5
Lung cancer: 7.51e-4
Expressed in all
GPRASP2G protein-coupled receptor associated sorting protein 2
Nucleoplasm
Cytosol		Renal cancer: 4.60e-6
Urothelial cancer: 6.63e-5
Pancreatic cancer: 5.71e-4
Mixed
RUNX2Runt-related transcription factor 2
NucleoplasmRenal cancer: 3.97e-9
Urothelial cancer: 6.66e-5
Stomach cancer: 2.24e-4
Mixed
EFEMP1EGF containing fibulin-like extracellular matrix protein 1
MitochondriaRenal cancer: 3.89e-8
Urothelial cancer: 6.68e-5
Endometrial cancer: 4.72e-4
Mixed
COL5A3Collagen, type V, alpha 3
Renal cancer: 7.17e-8
Urothelial cancer: 6.87e-5
Tissue enhancedplacenta:47.4
ARL4CADP-ribosylation factor-like 4C
Plasma membrane
Cytosol		Renal cancer: 3.69e-8
Endometrial cancer: 2.90e-7
Urothelial cancer: 6.99e-5
Mixed
FBN2Fibrillin 2
Nucleoplasm
Cytosol		Urothelial cancer: 7.41e-5
Tissue enriched8placenta:117.6
ARMC9Armadillo repeat containing 9
Nucleoli
Cytosol		Urothelial cancer: 7.66e-5
Mixed
TGFB1I1Transforming growth factor beta 1 induced transcript 1
Focal adhesion sites
Cytosol		Renal cancer: 6.06e-8
Urothelial cancer: 7.73e-5
Tissue enhancedendometrium:139.7
smooth muscle:151.9
SCDStearoyl-CoA desaturase (delta-9-desaturase)
Endoplasmic reticulumRenal cancer: 7.56e-5
Urothelial cancer: 7.79e-5
Expressed in all
NRP2Neuropilin 2
Vesicles
Plasma membrane		Renal cancer: 7.68e-7
Urothelial cancer: 7.80e-5
Mixed
EPN2Epsin 2
VesiclesUrothelial cancer: 8.15e-5
Renal cancer: 9.13e-5
Expressed in all
MAP1BMicrotubule-associated protein 1B
CytosolUrothelial cancer: 8.22e-5
Tissue enriched5cerebral cortex:188.2
MTHFD1LMethylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
MitochondriaCervical cancer: 1.68e-5
Liver cancer: 8.33e-5
Urothelial cancer: 8.69e-5
Head and neck cancer: 5.10e-4
Endometrial cancer: 7.28e-4
Mixed
DSTYKDual serine/threonine and tyrosine protein kinase
Nuclear speckles
Intermediate filaments		Urothelial cancer: 8.73e-5
Mixed
LAMC1Laminin, gamma 1 (formerly LAMB2)
Endoplasmic reticulum
Plasma membrane		Urothelial cancer: 8.85e-5
Tissue enhancedplacenta:330.2
TNFAIP6Tumor necrosis factor, alpha-induced protein 6
Cervical cancer: 8.18e-5
Urothelial cancer: 9.16e-5
Renal cancer: 5.59e-4
Tissue enhancedappendix:39.5
gallbladder:31.9
EVCEllis van Creveld protein
Nucleoplasm
Cytosol		Renal cancer: 5.60e-9
Urothelial cancer: 9.47e-5
Mixed
ITGA7Integrin, alpha 7
Plasma membrane
Cytosol		Urothelial cancer: 9.59e-5
Pancreatic cancer: 1.75e-4
Tissue enhancedadipose tissue:154.2
PTGISProstaglandin I2 (prostacyclin) synthase
Renal cancer: 4.74e-8
Urothelial cancer: 9.99e-5
Mixed
EPDR1Ependymin related 1
Urothelial cancer: 1.00e-4
Stomach cancer: 3.43e-4
Liver cancer: 6.97e-4
Expressed in all
COL14A1Collagen, type XIV, alpha 1
VesiclesRenal cancer: 5.79e-5
Urothelial cancer: 1.01e-4
Tissue enhancedcervix, uterine:277.0
PRELPProline/arginine-rich end leucine-rich repeat protein
Renal cancer: 5.62e-6
Colorectal cancer: 9.70e-5
Urothelial cancer: 1.02e-4
Mixed
UACAUveal autoantigen with coiled-coil domains and ankyrin repeats
Nucleus
Cytosol		Pancreatic cancer: 7.01e-5
Urothelial cancer: 1.03e-4
Renal cancer: 1.62e-4
Mixed
SNX29Sorting nexin 29
Renal cancer: 1.38e-7
Urothelial cancer: 1.03e-4
Mixed
PRMT5Protein arginine methyltransferase 5
Nucleus
Cytosol		Liver cancer: 4.77e-5
Urothelial cancer: 1.04e-4
Head and neck cancer: 1.82e-4
Pancreatic cancer: 2.61e-4
Expressed in all
PCOLCE2Procollagen C-endopeptidase enhancer 2
Nucleoplasm
Cytosol		Renal cancer: 1.96e-5
Urothelial cancer: 1.08e-4
Tissue enhancedadipose tissue:81.4
heart muscle:57.0
placenta:57.3

« prev | Page of 8 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.